Sophia Antipolis, France - Galderma's commitment to dermatology, and dermatology only, is nowhere more evident than in its sprawling, approximately 24,000-square-foot research and development facility in the south of France.
A Hairy Q&A With Jerry Shapiro, MD
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Evaluating Efficacy of Trifarotene in Latin American Patients With Acne
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Understanding Eyebrow and Eyelash Hair Loss in Severe Alopecia Areata
Incyte to Present Numerous Studies at EADV 2023
2 Clarke Drive Cranbury, NJ 08512